Bio-Imaging Technologies Market to Reach US$ 17.60 Billion by 2031 at 15.3% CAGR; North America Leads with 40% Share - Key Players: GE Healthcare, Hologic, Mindray

The global Bio-imaging Technologies market reached US$ 5.94 billion in 2023 and is projected to reach US$ 17.60 billion by 2031, registering a CAGR of 15.3 percent during the forecast period 2024-2031. The market is expanding steadily due to rising demand for advanced diagnostic tools, increasing prevalence of chronic diseases, and continuous technological progress in biomedical research. Growing investments in healthcare infrastructure, precision medicine, and imaging innovation are further contributing to market growth across clinical and research applications.

Bio-imaging technologies enable non-invasive visualization of biological processes, allowing researchers and clinicians to observe structures and functions with minimal disruption. These imaging methods provide detailed 3D representations of samples without physical interference, supporting accurate diagnosis, disease monitoring, and scientific discovery. The ability to capture high-resolution, real-time biological data continues to strengthen the role of bio-imaging in modern healthcare and life sciences.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/bio-imaging-technologies-market?sai-v

The Bio-imaging Technologies Market refers to the industry focused on advanced imaging systems and techniques used to visualize biological processes, tissues, and cells for medical diagnosis, research, and therapeutic monitoring.

Key Developments
✅ October 2025: Leading U.S. medical imaging innovators introduced AI-accelerated bio-imaging platforms capable of reducing scan interpretation time by over 40% while improving accuracy in early cancer and neurodegenerative disease detection.

✅ September 2025: European research hospitals deployed next-generation molecular imaging systems integrating PET-MRI fusion technology to enhance real-time visualization of cellular and metabolic activity.

✅ August 2025: Asia-Pacific diagnostic centers expanded use of high-resolution optical bio-imaging solutions for non-invasive tissue analysis in dermatology, ophthalmology, and regenerative medicine applications.

❇️ July 2025: Global biotechnology firms advanced nanoscale bio-imaging probes designed to track intracellular processes and monitor targeted drug delivery pathways.

✅ May 2025: Manufacturers launched ultra-fast ultrasound and photoacoustic imaging devices to support precision diagnosis in cardiovascular and oncology applications.

✅ March 2025: Academic research institutes increased adoption of 3D and 4D live-cell imaging technologies to study dynamic biological processes under physiologically relevant conditions.

Mergers & Acquisitions
❇️ November 2025: A U.S.-based medical imaging technology leader acquired a European molecular imaging software startup to strengthen its AI-driven diagnostic visualization capabilities.

✅ August 2025: A major European imaging equipment manufacturer formed a strategic partnership with an Asian nanotechnology company to co-develop next-generation nanoscale imaging agents.

✅ June 2025: A global life-science tools provider acquired a high-end microscopy and optical imaging firm to expand its advanced bio-imaging solutions for pharmaceutical and academic research.

Key Players
GE Healthcare | Abbott Laboratories | Hitachi Medical Corporation | Bayer AG | Esaote S.p.A | Clario | Digirad Corporation | Bracco | Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | Hologic Inc. | FONAR Corporation

Key Highlights
GE Healthcare - Holds a 19.4% share, driven by its strong portfolio in MRI, CT, ultrasound, and molecular imaging technologies, supported by continuous innovation and global clinical adoption.

Abbott Laboratories - Holds a 7.6% share, powered by its advanced diagnostic imaging systems, strong presence in contrast agents, and expanding integration of imaging-driven clinical solutions.

Hitachi Medical Corporation - Holds a 9.1% share, supported by its expertise in MRI, ultrasound, and advanced diagnostic imaging platforms with strong penetration in Asia-Pacific healthcare systems.

Bayer AG - Holds an 8.3% share, driven by its leadership in contrast media solutions, radiology workflow products, and end-to-end imaging support technologies.

Esaote S.p.A - Holds a 5.4% share, supported by its highly specialized ultrasound and MRI systems, with strong demand in cardiology, orthopedics, and veterinary imaging segments.

Clario - Holds a 4.7% share, powered by its expertise in medical imaging analytics, cloud-based imaging workflows, and advanced clinical trial imaging solutions.

Digirad Corporation - Holds a 3.9% share, driven by its mobile nuclear imaging systems, portable diagnostic solutions, and strong service network in point-of-care imaging.

Bracco - Holds a 6.8% share, supported by its leadership in contrast agents, imaging pharmaceuticals, and innovation in diagnostic imaging enhancement technologies.

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. - Holds a 12.2% share, fueled by its rapidly expanding imaging portfolio, strong global distribution, and cost-competitive ultrasound and radiology systems.

Hologic Inc. - Holds a 14.1% share, driven by its market leadership in women's imaging, including mammography, breast biopsy systems, and advanced tomosynthesis technologies.

FONAR Corporation - Holds a 2.5% share, supported by its pioneering upright MRI technology and niche-focused imaging solutions in musculoskeletal diagnostics.

Purchase this report before year-end and unlock an exclusive 30% discount: https://www.datamintelligence.com/buy-now-page?report=bio-imaging-technologies-market?sai-v
(Purchase 2 or more Reports and get 50% Discount)

Market Drivers

- Increasing prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions driving demand for advanced imaging solutions.

- Rising adoption of molecular imaging and functional imaging for early disease diagnosis and treatment planning.

- Technological advancements including AI-enabled image analysis, high-resolution imaging, and 3D/4D imaging modalities.

- Growth in minimally invasive and image-guided surgeries requiring precise visualization tools.

- Expanding use of bio-imaging in drug discovery, preclinical research, and biomarker identification.

- Rising investment in healthcare infrastructure and diagnostic centers, particularly in emerging markets.

- Increasing integration of digital imaging, cloud-based platforms, and PACS for efficient data management and remote diagnostics.

Industry Developments

- Introduction of next-generation hybrid imaging systems such as PET/CT, PET/MRI, and SPECT/CT for comprehensive diagnostic accuracy.

- Strategic partnerships between imaging equipment manufacturers and AI companies to enhance diagnostic workflows.

- Development of high-speed, high-precision imaging sensors for real-time clinical and research applications.

- Expansion of portable and point-of-care imaging technologies improving accessibility in remote areas.

- Rising investment in quantum imaging, photoacoustic imaging, and ultra-high-field MRI technologies.

- Growing deployment of cloud-integrated imaging platforms for cross-institutional collaboration and tele-radiology.

Regional Insights

North America - 40% share: "Driven by strong healthcare infrastructure, high adoption of advanced imaging modalities, and robust R&D investments."

Europe - 30% share: "Supported by increasing demand for precision diagnostics, rising chronic disease burden, and expansion of imaging research programs."

Asia Pacific - 22% share: "Fueled by rapid improvements in healthcare facilities, rising medical tourism, and increasing adoption of digital imaging technologies."

Latin America - 5% share: "Boosted by growing investments in diagnostic imaging equipment and expanding access to advanced healthcare services."

Middle East & Africa - 3% share: "Driven by rising prevalence of lifestyle diseases and increasing adoption of modern diagnostic imaging systems."

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/bio-imaging-technologies-market?sai-v

Key Segments

➥ By Technologies Type
• Nano-Bio Imaging: Utilizes nanotechnology-enabled contrast agents and probes for ultra-high-resolution cellular and molecular visualization.
• Radiological: Includes X-ray, CT, and PET imaging modalities providing detailed anatomical and functional insights for clinical diagnosis.
• Optical: Covers fluorescence, bioluminescence, and other light-based imaging techniques used for real-time and non-invasive biological observation.
• Magnetic Resonance: Uses MRI-based technologies to generate high-contrast, detailed soft-tissue images without ionizing radiation.
• Ultrasound Imaging: Employs sound waves to produce dynamic images of tissues and organs, widely used for safe and rapid diagnostics.
• Others: Includes hybrid imaging modalities and emerging techniques for advanced biomedical visualization and research.

➥ By Application
• Medical Bio-Imaging: Supports clinical diagnosis, treatment planning, disease monitoring, and surgical guidance across diverse medical specialties.
• Molecular Bio-Imaging: Focuses on imaging biological processes at the molecular and cellular levels, aiding research, drug discovery, and precision medicine.

➥ By End User
• Hospitals: Use advanced imaging technologies for comprehensive diagnostics, patient monitoring, and clinical decision-making.
• Diagnostic Centers: Provide specialized imaging services with high-throughput capabilities and access to advanced modalities.
• Others: Includes research institutes, biotechnology companies, and academic laboratories utilizing imaging for scientific studies and innovation.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.